Ablacath™ Mapping Catheter
K-Number: K223666 · 2023-03-17
Device Summary
Frequently Asked Questions
What is the Ablacath™ Mapping Catheter?
Ablacath™ Mapping Catheter is a medical device that received FDA 510(k) clearance on 2023-03-17. The listed applicant is Ablacon, Inc.. The 510(k) number is K223666.
When did Ablacath™ Mapping Catheter receive FDA 510(k) clearance?
Ablacath™ Mapping Catheter received FDA 510(k) clearance on 2023-03-17, under 510(k) number K223666.
Who is the listed applicant for Ablacath™ Mapping Catheter?
The FDA 510(k) record lists Ablacon, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Ablacath™ Mapping Catheter?
The FDA product code for Ablacath™ Mapping Catheter is MTD.
Other records listing Ablacon, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: MTD)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.